Zydus Wellness Limited (NSE:ZYDUSWELL)

Verve Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	27,275	27,089	23,278	22,548	20,091	18,667
Other Revenue	13	-	-	-	-	-
Revenue	27,288	27,089	23,278	22,548	20,091	18,667
Revenue Growth (YoY)	10.63%	16.37%	3.24%	12.23%	7.63%	5.65%
Cost of Revenue	12,926	12,781	11,384	11,593	9,926	8,588
Gross Profit	14,362	14,308	11,894	10,955	10,165	10,079
Selling, General & Admin	3,420	3,250	2,613	4,991	4,626	4,270
Other Operating Expenses	7,139	7,256	6,197	2,589	2,055	2,366
Operating Expenses	10,908	10,798	9,051	7,830	6,944	6,887
Operating Income	3,454	3,510	2,843	3,125	3,220	3,192
Interest Expense	-105	-116	-237	-158	-251.1	-834
Interest & Investment Income	31	31	110	32	92.9	67.6
Currency Exchange Gain (Loss)	1	-1	1	-2	-8.8	-
Other Non Operating Income (Expenses)	-17	3	1	-2	-4	-4
EBT Excluding Unusual Items	3,364	3,427	2,718	2,995	3,049	2,422
Gain (Loss) on Sale of Investments	99	99	25	16	11.1	21.8
Gain (Loss) on Sale of Assets	3	3	-	-1	-0.3	-
Other Unusual Items	59	59	-142	-101	-	-1,321
Pretax Income	3,525	3,588	2,601	2,909	3,060	1,122
Income Tax Expense	254	119	-68	-195	-28.5	-65.2
Earnings From Continuing Operations	3,271	3,469	2,669	3,104	3,089	1,187
Net Income	3,271	3,469	2,669	3,104	3,089	1,187
Net Income to Common	3,271	3,469	2,669	3,104	3,089	1,187
Net Income Growth	7.53%	29.97%	-14.01%	0.50%	160.15%	-16.22%
Shares Outstanding (Basic)	64	64	64	64	64	61
Shares Outstanding (Diluted)	64	64	64	64	64	61
Shares Change (YoY)	-0.00%	-	-	-	4.76%	5.34%
EPS (Basic)	51.41	54.52	41.94	48.78	48.54	19.55
EPS (Diluted)	51.41	54.52	41.94	48.78	48.54	19.55
EPS Growth	7.54%	29.97%	-14.01%	0.50%	148.33%	-20.47%
Free Cash Flow	-	3,137	2,179	467	1,614	2,671
Free Cash Flow Per Share	-	49.30	34.24	7.34	25.37	43.97
Dividend Per Share	-	6.000	5.000	5.000	5.000	5.000
Dividend Growth	-	20.00%	-	-	-	-
Gross Margin	52.63%	52.82%	51.09%	48.59%	50.59%	54.00%
Operating Margin	12.66%	12.96%	12.21%	13.86%	16.03%	17.10%
Profit Margin	11.99%	12.81%	11.47%	13.77%	15.37%	6.36%
Free Cash Flow Margin	-	11.58%	9.36%	2.07%	8.03%	14.31%
EBITDA	3,745	3,784	3,048	3,333	3,403	3,405
EBITDA Margin	13.73%	13.97%	13.09%	14.78%	16.94%	18.24%
D&A For EBITDA	291.25	274	205	208	182.2	213.2
EBIT	3,454	3,510	2,843	3,125	3,220	3,192
EBIT Margin	12.66%	12.96%	12.21%	13.86%	16.03%	17.10%
Effective Tax Rate	7.21%	3.32%	-	-	-	-
Revenue as Reported	27,404	27,225	23,417	22,597	20,195	18,756
Advertising Expenses	-	-	-	2,587	2,348	2,296

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.